NASDAQ: IRMD
Iradimed Corp Stock Ownership - Who owns Iradimed?

Insider buying vs selling

Have Iradimed Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John GlennCHIEF FINANCIAL OFFICER2024-12-022,500$54.18
$135.45kSell
Anthony VuotoDirector2024-11-062,690$55.99
$150.62kSell
John GlennCHIEF FINANCIAL OFFICER2024-06-201,412$42.53
$60.05kSell
John GlennCHIEF FINANCIAL OFFICER2024-06-201,412$42.53
$60.05kSell

1 of 1

IRMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IRMD insiders and whales buy or sell their stock.

IRMD Shareholders

What type of owners hold Iradimed Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Roger E. Susi36.08%4,587,950$266.88MInsider
Blackrock Inc7.44%946,300$55.05MInstitution
Nine Ten Capital Management LLC6.86%872,003$50.72MInstitution
Vanguard Group Inc4.36%554,451$32.25MInstitution
Renaissance Technologies LLC3.95%501,712$29.18MInstitution
Copeland Capital Management LLC3.86%490,544$28.53MInstitution
Geode Capital Management LLC1.93%245,390$14.27MInstitution
Serge Novovich1.92%244,636$14.23MInsider
Dimensional Fund Advisors LP1.73%220,175$12.81MInstitution
Ranger Investment Management LP1.57%200,110$11.64MInstitution

1 of 3

IRMD vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IRMD54.75%41.02%Net Selling
SIBN56.96%43.04%Net SellingNet Selling
SSII0.00%62.95%Net BuyingNet Buying
BBNX90.74%9.26%Net BuyingNet Selling
CBLL66.67%27.47%Net BuyingNet Buying

Iradimed Stock Ownership FAQ

Who owns Iradimed?

Iradimed (NASDAQ: IRMD) is owned by 54.75% institutional shareholders, 41.02% Iradimed insiders, and 4.24% retail investors. Roger E. Susi is the largest individual Iradimed shareholder, owning 4.59M shares representing 36.08% of the company. Roger E. Susi's Iradimed shares are currently valued at $266.88M.

If you're new to stock investing, here's how to buy Iradimed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.